Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
M.D. Anderson Cancer Center
University of Wisconsin, Madison
University of California, San Francisco
The Wellcome Sanger Institute
City of Hope Medical Center
National Cancer Institute (NCI)
Yonsei University
Mayo Clinic
National Cancer Institute (NCI)
Mayo Clinic
National Cancer Institute (NCI)
Thomas Jefferson University
University of Southern California
National Cancer Institute (NCI)
Mayo Clinic
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Mayo Clinic
Roswell Park Cancer Institute
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
Columbia University
University of California, San Francisco
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
Mayo Clinic
Mayo Clinic
Children's Oncology Group
Mayo Clinic
National Cancer Institute (NCI)
Mayo Clinic
Mayo Clinic
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
Centre Hospitalier Universitaire de Besancon
Mayo Clinic
Mayo Clinic
The Christie NHS Foundation Trust
University Health Network, Toronto